Myelo Therapeutics Closes Financing Round and Gains Strong Backing of Eckert & Ziegler Group
Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), announced today the successful closing of a multi-million Euro financing round, following…